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Sudomotor function in 
human poikilothermia
M.A. MacKenzie, MD; E. Schönbaum, PhD; A.R.M.M, Hermus, MD; H.C.H. Wollersheim, MD;
Th. Thien, MD; A.G.H. Smals, MD; and P.W.C. Kloppenborg, MD
A rticle abstract—Hypohidrosis predisposes to hyperthermia and may indicate generalized thermoregulatory failure. 
To assess the sweating capacity in hum an poikilothermia, we performed a quantitative analysis of the central and pe­
ripheral sudomotor pathways in four women with acquired poikilothermia (aged 29 to 38 years) and nine controls. 
Heat challenge in a climatic chamber (ambient temperature 40 °C, 50% relative humidity) for 180 minutes revealed 
that both sweat secretion and evaporative weight loss were significantly lower in the patients than in the controls (p < 
0.01). Temperature thresholds for thermal sweating were markedly elevated in at least two patients, whereas a third 
patient showed no sweating response. Stimulation of the eccrine sweat glands by intradermally injected acetylcholine 
during reduced core temperature (34.9 ± 0.7 °C) revealed a significantly reduced sweating response in all patients (p < 
0*01); the sudomotor response to pilocarpine iontophoresis was reduced or absent in three patients. We conclude that 
the generalized thermoregulatory sudomotor failure in these patients was attributable primarily to disorders of the 
central sudomotor drive; the impaired postganglionic sudomotor response is temperature related and possibly sec­
ondary to (long-standing) poikilothermia. Quantification of he at-dissipating capacity is pivotal for diagnosing severe 
thermolability and may help to prevent serious heat illness.
NEUROLOGY 1995;45:1602-1607
Human thermoregulation is achieved by a complex 
interaction of autonomic, endocrine, and behavioral 
responses; the skin plays an important role in both 
afferent and efferent thermoregulatory pathways. 
Hum ans have a lim ited physiologic capacity to 
withstand cold stress but can dissipate heat most 
effectively, principally by sweating and peripheral 
vasodilatation. If am bient tem perature exceeds 
body surface temperature, the only mechanism to 
maintain thermal equilibrium is evaporative heat 
loss; evaporation of 1 liter of sweat can remove 
2,450 kJ (585 kcal).
The control of therm al sweating is influenced by 
information from central and peripheral thermo­
receptors and is coordinated predominantly by the 
preoptic area/anterior hypothalamus1-3; the efferent 
sym pathetic sudomotor function is mediated by 
both preganglionic centers and postganglionic 
cholinergic pathways.4
Poikilothermia, defined as fluctuation in core 
temperature of more than 2 °C due to changes in 
the ambient temperature, is the most common dis­
order of thermoregulation in humans and is usually 
caused by lesions of the posterior hypothalamus or 
b ra in  s tem ,5 bu t its  pathophysiology rem ains 
largely unknown. The disorders of heat production
and heat conservation in poikilothermic patients 
predispose to marked hypothermia.”'0 However, if 
the preoptic region or peripheral heat-dissipating 
pathways are also affected, the patients are suscep­
tible to severe hyperthermia, including heat stroke, 
particularly in combination with inadequate behav­
ioral thermoregulation and possible use of drugs 
that suppress sudomotor function.n Decreased sweat 
secretion during supranormal core temperature has 
been reported in some patients with poikilother­
mia7'13; however, the sudomotor capacity in poikilo­
thermia has not yet been quantified.
We investigated the heat-dissipating mecha­
nisms in four patients with acquired poikilother­
mia, most probably of hypothalamic origin. We 
have previously demonstrated that our patients 
meet the definition of poikilothermia/5,7 We recently 
reported on the thermoregulatory responses to cold 
and heat challenge in our patients0 including some 
data on thermal sweating that are also described in 
the present study.
The rationale for the current study was to inves­
tigate the functional integrity of the central and pe­
ripheral sudomotor pathways by quantitative as­
sessment of thermoregulatory sweating and post­
ganglionic sudomotor responses in our patients.
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Methods. Sichjccts, We investigated four women, (aged 
29 to 38 years) with acquired poikilothermia. All patients 
bad a normal history of thermal sweating previous to the 
occurrence of poikilothermia but reported absence of 
sweating since then.
Patient 1 was a 29-year-old woman who was treated in 
1983 by surgery and radiation therapy for a large tumor 
near the corpus callosum with bilateral extension into 
the suprasellar cisterns; pathologically, no distinction be­
tween dysgerminoma, neuroblastoma, or atypical pin- 
eoblflstoma could be made. Postoperatively, she exhibited 
epilepsy, frontal lobe syndrome, and hypothalamic dys­
function, including partial diabetes insipidus, reduced 
thirst perception, increased appetite, hyperprolactinemia, 
and poikilothermia. Dependent on ambient temperature’ 
physical activity, and behavioral thermoregulation, core 
temperature was most of the time between 35.0 and 88.6 
°C. On hot summer days core temperature exceeded 40 
°C, causing progressive drowsiness, confusion, restless­
ness, and decreased consciousness; no sweating has been 
noticed since 1983.
P a tien t 2 was a 38-year-old woman with no relevant 
medical history until 1982, when epilepsy, secondary 
amenorrhea, and poikilothermia were demonstrated. 
Neuroendocrinoiogic evaluation revealed no well-known 
causes of thermolability; CT and MRI of the cerebrum 
showed no evidence of hypothalamic or pituitary lesions. 
Core temperature ranged from 31,4 to 35.2 °C and in­
creased up to 38.2 °C during exposure to a hot environ­
ment without provoking visible sweating.
P atien t 3 was a 34-year-old woman in whom panhypopi­
tuitarism and marked thermolability were demonstrated 
in 1982. MM of the cerebrum in 1990 showed an empty 
sella. Core temperature ranged from 32,9 to 37.0; eleva­
tion up to 38 °C induced severe discomfort, agitation, 
confusion, and impaired judgment but no sweating.
P a tien t 4 was a 31-year-old woman who suffered from 
epilepsy, post-traumatic encephalopathy, and marked 
hypothermia after extensive cerebral damage due to a 
traffic accident at age 16, CT of the cerebrum in 1978 re­
vealed marked central atrophy of the hemispheres, in­
cluding bilateral thalamic lesions. Core temperature usu­
ally varied from 31.7 to 36 °C but increased up to 36 to 
37 °C during the 4 months preceding the present study, 
presumably due to ameliorated control by her environ­
ment. Sweat secretion was never observed.
The patients received no anticholinergics or other medi­
cation known to interfere with sweat secretion, except for 
patient 4, who was treated with carbamazepine 200 mg 
per clay throughout this study and clomipramine up to 4 
weeks before this study. A more detailed description of 
the clinical and biochemical data of our patients has been
published elsewhere.
Nine healthy women, matched for age and body mass
index, served as controls for the patients; the physical
characteristic« of all participants are listed in the table.
All controls had a normal history of thermal sweating and
did not use any medication. To reduce possible effects of
the menstrual cycle on the sweat response, all controls
and the two nonamenorrheic patients (nos, 1 and 4) were
studied during days 5 to 11 of the menstrual cycle. None
of the participants was acclimated to heat stress.
Table. Physical characteristics of subjects
C o n tro ls P a t i e n t s
(n = 9) 1 2 3 4
Age (yr) 33.9 ± 3.1 29 38 34 31
Sex F F F F F
Height (m) 1.72 ±0.07 1.71 1.62 1.68 1.66
Weight (kg) 68.6 ± 7.9 81.0 68.1 65,9 70.1
Body mass index 23.3 ± 2.8 27,7 25.9 23.3 25.4
(kg/m2)
Body fat(%)* 30.3 ±3.5 39.6 37.5 37.9 35.2
*p < 0.05 (Wilcoxori’s rank sum test; controls versus patients).
The experimental procedures were approved by the 
Local Ethical Committee; informed consent was obtained 
from all participants.
Investigations. Thermoregulatory sweat test. Preceding 
heat exposure, baseline values (vide infra) were obtained 
in a thermoneutral climatic chamber (ambient tempera­
ture [Tarab] 29 °C, 50% relative humidity) during 50 min­
utes after a 45-minute acclimatization period, All sub­
jects were investigated in supine position on a comfort­
able examination table, dressed in bikini, and were al­
lowed to drink limited amounts of tepid water. The wind 
velocity was less than 0.1 m/sec.
Assessment of the he at-dissipating capacity was per­
formed during a 180-minute exposure to intense heat 
stress in a climatic chamber (Tamb 40 °C, 50% relative hu­
midity). To avoid severe discomfort and heat illness, 
thermal stress was terminated if rectal temperature (Tr ) 
exceeded 38.5 °C.
To estimate the total weight loss due to sweating, the 
body weight was recorded on a precision balance (accu­
racy, ±5 g) preceding and immediately after heat stress, 
after drying the patient with a towel. The total evapora­
tive weight loss was assessed by continuous recording of 
changes in total body weight by means of a Potter bed 
balance (accuracy, ±5 g). Changes in body weight were 
corrected for intake of liquid as well as respiratory and 
metabolic weight loss, according to Snellen.14 For 50 min­
utes before heating and during heat stress, the local 
evaporation ra te  was recorded every 10 minutes by 
means of an evaporimeter16 (Evaporimeter Epl, Ser- 
voMed AB, Stockholm, Sweden) applied to five sites: 
forehead (a), chest (b), abdomen (c), ventral thigh (d), 
and ventral forearm (e). Based on the relative areas of 
body surface of DuBois,16 the weighted mean local evapo­
ration rate (Evaploc) was calculated according to Evaploc = 
0.1029a + 0.2574(b + c) + 0.2794d + 0.1029e.
Rectal temperature was recorded simultaneously by 
means of a probe with thermistor (depth of insertion, 10 
cm) attached to a Squirrel datalogger (type Grant SQ- 
1201, Grant Instruments Ltd, Barrington, Cambridge 
CB2 5QZ, England). Skin temperatures were recorded 
with thermistors (YSI 409B, Yellow Springs Instrument 
Co, Yellow Springs, OH) from eight sites: forehead (A), 
parasternal (B) and para-umbilical (C) regions, medial 
thigh (D), lateral calf (E), lateral upper arm (F), ventro­
lateral forearm (G), and hand palm (H). The mean skin 
temperature (Takin) was computed according to Gagge 
and Nishi,17 (with abdomen replacing back): Takill =
0.07A + 0.175(B + C) + 0.07(F + G) + 0.05H + 0.19D +
0.2E. To calculate the weighted mean skin temperature 
at the sites of the recording of the Evap!oc (I'skinievap)) 5
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equation for the Evaploc was applied to the corresponding 
five skin sites.
Acetylcholine test. The response of eccrine sweat 
glands to intradermally injected acetylcholine was deter­
mined at room temperature (Tamb ± 22 °C), normal rela­
tive humidity, and minimum air convection; both pa­
tients and controls (see above) were wearing standard 
clothing. Local evaporation was recorded continuously by 
means of an evaporimeter for 10 minutes before and 60 
minutes after pharmacologic sweat stimulation. Acetyl­
choline (0.1%/0.1 ml) was injected on the flexor surface of 
the forearm (approximately 10 cm distal to the elbow), 
with an indwelling intradermal 25-gauge needle, by the 
same investigator in all cases. The epidermis was perfo­
rated outside the actual measuring site; the drug was in­
jected after the needle was moved approximately 1 cm in- 
tradermally into the test site center. Peak and total (ex­
pressed as area under the curve, corrected for baseline 
values) evaporative responses to acetylcholine were as­
sessed. The rectal and local skin tem peratures were 
recorded with thermistors; due to technical limitations 
this was performed only in the patients.
To examine the effect of normalization of core temper­
ature on sudomotor function, testing the  sweating re­
sponse to acetylcholine was repeated in two patients 
(nos. 2 and 3) after several days of steady state normo- 
thermia, which was achieved by a higher ambient tem­
perature, increased insulation, and use of an electric 
blanket.
Pilocarpine test. The sweat response to pilocarpine on 
the contralateral forearm at the corresponding site was 
determined simultaneously with acetylcholine testing. 
Pilocarpine nitrate (Ionto-Pad, Orion Research Inc, Cam­
bridge, MA) 1% was administered by iontophoresis for 5 
minutes with 2 mA direct current from an Orion (model 
417, Orion Research Inc) potentiometer. Thereafter, the 
quantity of the sweat response of the stimulated area for 
45 minutes was estimated by means of a Macroduct cap­
illary collection device (Wescor Instruments, Logan, UT).
Sweat gland biopsy. To assess whether putative sudo­
m otor d y sfu n c tio n  w as re la te d  to h is topa tho log ic  
changes, supra-iliac skin biopsies were performed in two 
patients (nos. 2 and 3).
Statistica l analysis. The Wilcoxon rank  sum test was 
applied for comparison of the sweating responses with 
thermal stress and pilocarpine iontophoresis between pa­
tients and control subjects. Regarding the sweating re­
sponse to acetylcholine, intra- and intergroup compar­
isons were performed by repeated  m easures ANOVA 
with multiple comparison procedures by means of the 
contrast option of the General Linear Models procedure 
(SAS Institu te  Inc, Cary, NC; p  value in this case de­
noted by p*). Values of p < 0.05 were considered to indi­
cate statistical significance. The results are expressed as 
means ± SD unless indicated otherwise.
Results. Thermoregulatory sweat test All partici­
pants were exposed to heat for 180 minutes; only in 
patien t 2, h ea t stress was term inated after 120 
minutes (due to distress and Tr exceeding 38.6 °C). 
At the end of thermal stress, both total body weight 
reduction (646 ± 103 g [range, 459 to 780] versus 
101 ± 102 g [range, 26 to 247], p  < 0.01) and evapo­
rative weight loss (407 ± 61 g [range, 312 to 530] 
versus 64 ± 67 g [range, 18 to 162], p  < 0.01) were
1604 NEUROLOGY 45 August 1995
significantly greater in the controls than in the pa­
tients.
At thermoneutrality, the local evaporation rate 
was comparable in the patients and controls (8.6 ±
3.2 g/m2h versus 9.6 ± 2.5 g/m2h, p = ns), despite 
significantly lower Tr (35.3 ± 0.3 °C versus 37.0 ± 
0.3 °C, p  < 0.01) and T ^ evan) (33*2 ± O-7 °C versus 
34.3 ± 0.4 °C, p  < 0.05) in the patients. In all con­
trols, sweating started within 5 minutes after the 
beginning of heat exposure; in contrast, in the pa­
tients either no sweating occurred (patient 1) or the 
sweating response was markedly delayed and re­
duced. The relation between the onset of sweating 
and both Tr and Tskin is depicted in figure 1. Sweat­
ing in patients 2 and 3 started after 60 minutes 
heating (Tskin(evap) 37.7 °C in patient 2 and 37.0 °C in 
patien t 3) and in patien t 4 after 130 m inutes 
(Tgkin(evaP) 37.8 °C). The sweat response was limited 
to the forehead and upper torso in p a tien t 2, 
whereas patients 3 and 4 showed more generalized 
thermal sweating. Patient 1 showed no increase in 
evaporation rate despite core and skin tempera­
tures exceeding 38.5 °C.
Acetylcholine test The sweating response to in­
tradermal injection of acetylcholine is depicted in 
figure 2. The evaporation rate in the controls in­
creased significantly from 8.8 ± 3.9 g/m2h to a max­
imum of 196.9 ± 22.6 g/m2h (range, 170 to 234; p * < 
0.0001); compared with baseline value, the evapo­
ration rate remained significantly enhanced during 
the entire recording.
The evaporation rate in the patients increased 
significantly after acetylcholine injection from 6.5 ±
4.0 g/m2h to a maximum of 78.5 ± 38.6 g/m2h 
(range, 32 to 115; p* < 0.05). However, the maxi­
mum evaporation rate was significantly decreased 
in the patients as compared with the controls (p < 
0.01); the same applied to the cumulative response 
to acetylcholine (2,079 ± 1,618 g/m2h [range, 519 to 
4,273] versus 6,233 ± 1,048 g/m2h [range, 4,418 to 
8,336], p  < 0.01). However, at the time of the experi­
ment, Tr in patients 1 to 4 was markedly reduced 
(35.6, 35.5, 34,2, and 34.4 °C [mean, 34.9 ± 0.7]; the 
corresponding local skin tem perature was 30.1, 
30.6, 30.6, and 27,1 °C [mean, 29.6 ± 1.7]). The max­
imum evaporation rate in the patients was reached 
at approximately the same time after stimulation as 
in the controls but was delayed in patient 4.
Normothermia in patients 2 (Tr 36.9 °C) and 3 
(Tr 36,5 °C) induced a rise of 0.6 °C (patient 2) and
0.9 °C (patient 3) in local skin temperature and an 
increase in maximum evaporation rate from 32 to 
80 g/m2h (patient 2) and from 105 to 134 g/m2h (pa­
tient 3).
Pilocarpine test, Pilocarpine iontophoresis in­
duced a secretion of 32,6 ± 11.4 (jlI (range, 20 to 57,5) 
sweat in the controls during a 45-minute period. The 
sweating response to pilocarpine was attenuated in 
three patients (0 jol, patient 1; 0 jxl, patient 2; and 15 
fxl, patient 3) but markedly enhanced (70 (jlD in pa­
tient 4. At the time of the test, Tr in the patients 1 to 
4 was 35.1, 35.1, 34.2, and 34.4 °C.
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from preganglionic or central lesions by testing 
both the thermoregulatory sweating and sudomotor 
reflex. The sym pathetic sudomotor response to 
acetylcholine is mediated by both muscarinic and 
nicotinic receptors, whereas pilocarpine is consid­
ered to bind directly to the muscarinic receptor on 
the eccrine sweat gland.4,25 Although the sweating 
response to pilocarpine was markedly blunted or 
absent in three patients, the positive (although re­
duced) response to acetylcholine in all patients in­
dicated an at least partly intact local sympathetic 
supply. Patients with more serious impairment of 
thermal sweating also showed lower sweating re­
sponses to cholinergics. The enhanced sudomotor 
response to pilocarpine in patien t 4, despite re ­
duced thermal and acetylcholine-induced sweating, 
might be attributed to supersensitivity of the mus­
carinic m echanism s by carbam azepine or w ith­
drawal of clomipramine.26
The sudomotor responsiveness to cholinergics is 
affected by local skin and core tem peratures,4,27*28 
notably mediated by the rate of transm itter release 
at the neuroglandular junction and degree of glan­
dular response.21 The impaired cholinergic sudomo­
tor response in the patients might be attributable 
to the reduced core and (local) skin temperature at 
the time of the test. However, the sudomotor re­
sponse to acetylcholine in patients 2 and 3 during 
normothermia rem ained subnormal. The attenu­
ated sudomotor response might be caused also by 
impaired secretory capacity or decreased number of 
active sweat glands due to functional inactivity 
during prolonged periods of hypothermia, which 
might be considered as a counterpart of heat ac­
climatization in therm al sweating after a rise in 
body temperature.29 However, no histologic abnor­
malities were found in sweat gland biopsies. Gener­
alized hypohidrosis and a decreased postganglionic 
sudomotor response can be caused by generalized 
autonomic failure, multiple system atrophy, vari­
ous drugs, and many chronic (skin) disorders30-34; 
however, in our patients these causes were not re­
sponsible for the sudomotor dysfunction. Therefore, 
we hypothesize th a t in addition to the reduced core 
and local skin temperature, long-standing absence 
of adequate sudomotor stim ulation and possibly 
secondary degeneration of sudomotor axons may 
contribute to the acquired sudomotor failure.
Because anhidrosis may easily be misdiagnosed 
in the case of rapid invisible sweat evaporation,19 
quantitative analysis of sweating capacity is a pre­
requisite to establish thermoregulatory sudomotor 
failure, which may occur in combination with an in­
tact cholinergic sudomotor response. Continuous 
recording of the evaporative weight reduction is ad­
equate to assess to ta l h ea t d issipation ,17-20 and 
recording the local evaporation ra te  at multiple 
sites makes it possible to assess topographic differ­
ences. If inadequate therm oregulatory sweating 
has been demonstrated despite supranormal tem­
peratures of core and skin, the sudomotor response 
to cholinergics must be assessed complementarily
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to differentiate between postganglionic and pregan­
glionic or central lesions. Additionally, sudomotor 
analysis during prolonged physical exercise may be 
useful, but this failed to induce an increase in ther­
mal sweating during either hypothermia or nor­
mothermia in our patients (unpublished data). Fur­
thermore, impaired heat dissipation can be caused 
partly by inadequate skin vasodilatation; based on 
marked reddening of the skin and the high skin 
blood flow during heat stress,6 this obviously was 
not the case in our patients.
The present study has some limitations. First, 
during thermal stress, core and skin temperatures 
all changed simultaneously and were recorded in­
termittently, thereby hampering exact determina­
tion of core and skin temperature thresholds for 
thermal sweating. Second, at the start of heating, 
rectal and mean skin temperature were lower in 
the patients; however, even after the onset of ther­
mal sweating, the rate of evaporative weight loss 
remained much lower in patients than in controls. 
Third, local skin temperature was not recorded in 
controls during testing of the cholinergic sudomotor 
response; however, the local skin temperature of 
the forearm in the thermoneutral climatic chamber 
was only 0.7 °C lower in the patients than in the 
controls, making it unlikely that this variable sig­
nificantly influenced the differences in sudomotor 
response. Fourth, the high humidity and low air ve­
locity during heat stress decreased the evaporative 
capacity. However, based on previously observed 
absence of visible sweating,7 the high heat load was 
necessary to differentiate between anhidrosis or 
merely elevation of the temperature thresholds for 
sweating. Furthermore, the exact location of the 
heterogenic preganglionic lesions remains uncer­
tain, and adaptation of the thermal- and choliner­
gic-induced sudomotor response to long-standing 
normothermia requires further elucidation. Ther­
mal sweating and sudomotor responses might be 
improved by prolonged normothermia, especially if 
combined with intermittent heat stress, physical 
training, or drugs that enhance sweating.
Decreased thermostability and hypohidrosis pre­
dispose to serious heat illness in a hot environment, 
especially in combination with physical exercise, in­
adequate behavioral thermoregulation, dehydra­
tion, or chronic (cardiovascular) disorders.3,4,6'32'35 
Recognition of impaired heat tolerance is often diffi­
cult6*10*36—particularly in patients with poikilother­
mia who tend to have prolonged hypothermia in 
cold and moderate climates—but is pivotal for diag­
nosing poikilothermia and for differentiating be­
tween hyperthermia and fever.:,r>,:17 Because anhidro­
sis may indicate generalized thermoregulatory fail­
ure with potentially serious s e q u e l a e , a  careful 
history and investigation of the sweating capacity 
and putative precipitating disorders is indicated in 
hyperthermia without obvious cause. The diagnosis 
of poikilothermia should be taken into account in 
patients with decreased thermostability, especially 
if other autonomic or endocrine disorders exist. In
poikilothermia, considerable fluctuations in core 
temperature greatly affect physical and neuropsy­
chiatrie function, and adequate monitoring of core 
temperature and amelioration of thermoregulatory 
behavior may help to prevent serious complications 
of both hypothermia and hyperthermia.
Our results demonstrate generalized deficiency 
of thermoregulatory sweating in our patients with 
acquired poikilothermia, attributable primarily to a 
defect in the central thermal drive; the impaired 
postganglionic sudomotor response is partly related 
to the lower core and skin temperature and possi­
bly also to (longstanding) absence of sudomotor 
stimulation. We emphasize that a careful history 
and quantitative assessment of sweating capacity 
in patients with heat intolerance is essential to rec­
ognize serious hypohidrosis or generalized ther­
moregulatory failure and can thereby help to pre­
vent the complications of severe hyperthermia.
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